Management of Cancer Cachexia: Attempting to Develop New Pharmacological Agents for New Effective Therapeutic Options
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Management of Cancer Cachexia: Attempting to Develop New Pharmacological Agents for New Effective Therapeutic Options
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-03-04
DOI
10.3389/fonc.2020.00298
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review
- (2019) Markus S. Anker et al. Journal of Cachexia Sarcopenia and Muscle
- Circulating miR‐203 derived from metastatic tissues promotes myopenia in colorectal cancer patients
- (2019) Yoshinaga Okugawa et al. Journal of Cachexia Sarcopenia and Muscle
- TLR/MyD88/XBP1 signaling axis mediates skeletal muscle wasting during cancer cachexia
- (2019) Kyle R. Bohnert et al. MOLECULAR AND CELLULAR BIOLOGY
- Toll-like receptor-induced cytokines as immunotherapeutic targets in cancers and autoimmune diseases
- (2019) Mahesh Chandra Patra et al. SEMINARS IN CANCER BIOLOGY
- Cachexia induced by Yoshida ascites hepatoma in Wistar rats is not associated with inflammatory response in the spleen or brain
- (2019) Alena Cernackova et al. JOURNAL OF NEUROIMMUNOLOGY
- Modeling Human Cancer-induced Cachexia
- (2019) Erin E. Talbert et al. Cell Reports
- Development and Characterization of a Genetic Mouse Model of KRAS Mutated Colorectal Cancer
- (2019) Radhashree Maitra et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer
- (2019) Katherine A. Michaelis et al. Nature Communications
- Metformin prevents the pathological browning of subcutaneous white adipose tissue
- (2019) Christopher Auger et al. Molecular Metabolism
- Cancer cachexia: Diagnosis, assessment, and treatment
- (2018) Mohammadamin Sadeghi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Twist1 Activation in Muscle Progenitor Cells Causes Muscle Loss Akin to Cancer Cachexia
- (2018) Parash Parajuli et al. DEVELOPMENTAL CELL
- Bridging the gap: are animal models consistent with clinical cancer cachexia?
- (2018) Vickie E. Baracos Nature Reviews Clinical Oncology
- Fenofibrate prevents skeletal muscle loss in mice with lung cancer
- (2018) Marcus D. Goncalves et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial
- (2018) Jenny G. Turcott et al. SUPPORTIVE CARE IN CANCER
- Cancer-associated cachexia
- (2018) Vickie E. Baracos et al. Nature Reviews Disease Primers
- The TLR7/8/9 antagonist IMO-8503 inhibits cancer-induced cachexia
- (2018) Federica Calore et al. CANCER RESEARCH
- Ghrelin as a Promising Therapeutic Option for Cancer Cachexia
- (2018) Mahalaqua Nazli Khatib et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial
- (2018) Talia Golan et al. Journal of Cachexia Sarcopenia and Muscle
- TLR Stimulation During T-cell Activation Lowers PD-1 Expression on CD8+ T Cells
- (2018) Christopher D. Zahm et al. Cancer Immunology Research
- Preservation of muscle mass as a strategy to reduce the toxic effects of cancer chemotherapy on body composition
- (2018) Fabrizio Pin et al. Current Opinion in Supportive and Palliative Care
- Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
- (2018) Jacob O'Brien et al. Frontiers in Endocrinology
- Pharmacological management of cachexia in adult cancer patients: a systematic review of clinical trials
- (2018) Shailesh M. Advani et al. BMC CANCER
- Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression
- (2018) Qi Wu et al. Molecular Cancer
- Toll-Like Receptor-4 Disruption Suppresses Adipose Tissue Remodeling and Increases Survival in Cancer Cachexia Syndrome
- (2018) Felipe Henriques et al. Scientific Reports
- Myokines as Possible Therapeutic Targets in Cancer Cachexia
- (2018) Emilia Manole et al. Journal of Immunology Research
- The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia
- (2017) David C Currow et al. Future Oncology
- MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study
- (2017) Tamas Hickish et al. LANCET ONCOLOGY
- Orthotopic Patient-Derived Pancreatic Cancer Xenografts Engraft Into the Pancreatic Parenchyma, Metastasize, and Induce Muscle Wasting to Recapitulate the Human Disease
- (2017) Kristina L. Go et al. PANCREAS
- Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy
- (2017) Frederic Morvan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Spontaneous recombinase activity of Cre–ERT2 in vivo
- (2017) Jasmin Kristianto et al. TRANSGENIC RESEARCH
- Current Understanding of the Hypothalamic Ghrelin Pathways Inducing Appetite and Adiposity
- (2017) Omar Al Massadi et al. TRENDS IN NEUROSCIENCES
- Erratum to: Update on Management of Cancer-Related Cachexia
- (2017) Lindsey J. Anderson et al. Current Oncology Reports
- Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90
- (2017) Guohua Zhang et al. Nature Communications
- Establishment and characterization of a novel murine model of pancreatic cancer cachexia
- (2017) Katherine A. Michaelis et al. Journal of Cachexia Sarcopenia and Muscle
- Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics
- (2017) Wei Gao et al. Frontiers in Physiology
- Cancer-induced muscle wasting: latest findings in prevention and treatment
- (2017) Zaira Aversa et al. Therapeutic Advances in Medical Oncology
- Efect of ALD518, a humanized anti-IL-6 antibody, on lean body mass loss and symptoms in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II randomized, double-blind safety and efficacy trial.
- (2017) J. R. Rigas et al. JOURNAL OF CLINICAL ONCOLOGY
- Isolation of Pancreatic Cancer Cells from a Patient-Derived Xenograft Model Allows for Practical Expansion and Preserved Heterogeneity in Culture
- (2016) Kien Pham et al. AMERICAN JOURNAL OF PATHOLOGY
- PTH/PTHrP Receptor Mediates Cachexia in Models of Kidney Failure and Cancer
- (2016) Serkan Kir et al. Cell Metabolism
- Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity
- (2016) Thomas R. Flint et al. Cell Metabolism
- Key determinants of energy expenditure in cancer and implications for clinical practice
- (2016) S A Purcell et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials
- (2016) Jennifer S Temel et al. LANCET ONCOLOGY
- Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia
- (2016) Tomoya Fukawa et al. NATURE MEDICINE
- Brown adipose tissue as a secretory organ
- (2016) Francesc Villarroya et al. Nature Reviews Endocrinology
- From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology
- (2016) Alessia Ligresti et al. PHYSIOLOGICAL REVIEWS
- STAT3 in the systemic inflammation of cancer cachexia
- (2016) Teresa A. Zimmers et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Megestrol Acetate–Induced Adrenal Insufficiency
- (2016) Sowmya Nanjappa et al. Cancer Control
- New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss
- (2016) Neil Johns et al. Journal of Cachexia Sarcopenia and Muscle
- Aerobic Exercise and Pharmacological Treatments Counteract Cachexia by Modulating Autophagy in Colon Cancer
- (2016) Eva Pigna et al. Scientific Reports
- Autophagy is induced in the skeletal muscle of cachectic cancer patients
- (2016) Zaira Aversa et al. Scientific Reports
- Patient-Derived Xenograft Models for Pancreatic Adenocarcinoma Demonstrate Retention of Tumor Morphology through Incorporation of Murine Stromal Elements
- (2015) Daniel Delitto et al. AMERICAN JOURNAL OF PATHOLOGY
- Skeletal muscle as an endocrine organ: PGC-1α, myokines and exercise
- (2015) Svenia Schnyder et al. BONE
- Cachexia: A preventable comorbidity of cancer. A T.A.R.G.E.T. approach
- (2015) Maurizio Muscaritoli et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia
- (2015) Danielle N. Seto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia
- (2015) Yu-Chou Tseng et al. JNCI-Journal of the National Cancer Institute
- Regulation of autophagy and the ubiquitin–proteasome system by the FoxO transcriptional network during muscle atrophy
- (2015) Giulia Milan et al. Nature Communications
- Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia
- (2015) Yu-Chou Tseng et al. JNCI-Journal of the National Cancer Institute
- Adipose tissue lipolysis and energy metabolism in early cancer cachexia in mice
- (2014) Kara L Kliewer et al. CANCER BIOLOGY & THERAPY
- Cancer-Secreted miR-105 Destroys Vascular Endothelial Barriers to Promote Metastasis
- (2014) Weiying Zhou et al. CANCER CELL
- A Switch from White to Brown Fat Increases Energy Expenditure in Cancer-Associated Cachexia
- (2014) Michele Petruzzelli et al. Cell Metabolism
- Coming back
- (2014) Fabio Penna et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Involvement of MicroRNAs in the Regulation of Muscle Wasting during Catabolic Conditions
- (2014) Ricardo José Soares et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HDAC1 activates FoxO and is both sufficient and required for skeletal muscle atrophy
- (2014) A. W. Beharry et al. JOURNAL OF CELL SCIENCE
- Pharmacological Inhibition of Myostatin and Changes in Lean Body Mass and Lower Extremity Muscle Size in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer
- (2014) Desmond Padhi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study
- (2014) David S Hong et al. LANCET ONCOLOGY
- Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia
- (2014) Serkan Kir et al. NATURE
- Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin
- (2014) Jan Mauer et al. NATURE IMMUNOLOGY
- Depletion of White Adipose Tissue in Cancer Cachexia Syndrome Is Associated with Inflammatory Signaling and Disrupted Circadian Regulation
- (2014) Maria Tsoli et al. PLoS One
- Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7
- (2014) W. A. He et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lipolysis in lipid turnover, cancer cachexia, and obesity-induced insulin resistance
- (2014) Peter Arner et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Parathyroid hormone and parathyroid hormone type-1 receptor accelerate myocyte differentiation
- (2014) Shigemi Kimura et al. Scientific Reports
- Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile
- (2014) Claudio Pietra et al. Journal of Cachexia Sarcopenia and Muscle
- Autophagic-lysosomal pathway is the main proteolytic system modified in the skeletal muscle of esophageal cancer patients
- (2013) Nicolas Tardif et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?
- (2013) Carla M Prado et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Autophagic Degradation Contributes to Muscle Wasting in Cancer Cachexia
- (2013) Fabio Penna et al. AMERICAN JOURNAL OF PATHOLOGY
- Clinical Studies on the Treatment of Cancer Cachexia with Megestrol Acetate plus Thalidomide
- (2013) Hong-Sheng Wen et al. CHEMOTHERAPY
- The activins and their binding protein, follistatin—Diagnostic and therapeutic targets in inflammatory disease and fibrosis
- (2013) M.P. Hedger et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Elevated expression of activins promotes muscle wasting and cachexia
- (2013) Justin L. Chen et al. FASEB JOURNAL
- NF-κB–mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia
- (2013) Wei A. He et al. JOURNAL OF CLINICAL INVESTIGATION
- Erythropoietin administration partially prevents adipose tissue loss in experimental cancer cachexia models
- (2013) Fabio Penna et al. JOURNAL OF LIPID RESEARCH
- An Antibody Blocking Activin Type II Receptors Induces Strong Skeletal Muscle Hypertrophy and Protects from Atrophy
- (2013) E. Lach-Trifilieff et al. MOLECULAR AND CELLULAR BIOLOGY
- Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment
- (2013) Sumbul Ali et al. Current Opinion in Supportive and Palliative Care
- Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma
- (2012) C M M Prado et al. BRITISH JOURNAL OF CANCER
- Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients
- (2012) Yuichiro Hiura et al. CANCER
- Causes and Consequences of MicroRNA Dysregulation
- (2012) Marilena V. Iorio et al. CANCER JOURNAL
- Activation of Thermogenesis in Brown Adipose Tissue and Dysregulated Lipid Metabolism Associated with Cancer Cachexia in Mice
- (2012) M. Tsoli et al. CANCER RESEARCH
- FAT SIGNALS - Lipases and Lipolysis in Lipid Metabolism and Signaling
- (2012) Rudolf Zechner et al. Cell Metabolism
- Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer
- (2012) S. Adams et al. CLINICAL CANCER RESEARCH
- Clinical Applications for microRNAs in Cancer
- (2012) S P Nana-Sinkam et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Myostatin: more than just a regulator of muscle mass
- (2012) Josep M. Argilés et al. DRUG DISCOVERY TODAY
- The Role of Thalidomide and Placebo for the Treatment of Cancer-Related Anorexia-Cachexia Symptoms: Results of a Double-Blind Placebo-Controlled Randomized Study
- (2012) Sriram Yennurajalingam et al. JOURNAL OF PALLIATIVE MEDICINE
- Understanding the mechanisms and treatment options in cancer cachexia
- (2012) Kenneth Fearon et al. Nature Reviews Clinical Oncology
- JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
- (2012) Claire Harrison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial
- (2011) T. D. Brisbois et al. ANNALS OF ONCOLOGY
- Is there a genetic cause for cancer cachexia? – a clinical validation study in 1797 patients
- (2011) T S Solheim et al. BRITISH JOURNAL OF CANCER
- Targeting Protein Synthesis in a Myc/mTOR-Driven Model of Anorexia-Cachexia Syndrome Delays Its Onset and Prolongs Survival
- (2011) F. Robert et al. CANCER RESEARCH
- Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome
- (2011) Clelia Madeddu et al. CLINICAL NUTRITION
- C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting
- (2011) Guohua Zhang et al. EMBO JOURNAL
- A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer
- (2011) Trevor J Bayliss et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Cell-type specific regulation of myostatin signaling
- (2011) Dwi U. Kemaladewi et al. FASEB JOURNAL
- Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
- (2011) Mübeccel Akdis et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers
- (2011) Tanios Bekaii-Saab et al. JOURNAL OF CLINICAL ONCOLOGY
- Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic–pituitary–adrenal axis
- (2011) Theodore P. Braun et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Adipose zinc-α2-glycoprotein is a catabolic marker in cancer and noncancerous states
- (2011) M. Rydén et al. JOURNAL OF INTERNAL MEDICINE
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis
- (2011) Khoa D. Nguyen et al. NATURE
- The Regulation of Skeletal Muscle Protein Turnover during the Progression of Cancer Cachexia in the ApcMin/+ Mouse
- (2011) James P. White et al. PLoS One
- Myostatin blockage using actRIIB antagonism in mice bearing the Lewis lung carcinoma results in the improvement of muscle wasting and physical performance
- (2011) Sílvia Busquets et al. Journal of Cachexia Sarcopenia and Muscle
- Body composition in patients with non−small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis
- (2010) Vickie E Baracos et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer
- (2010) E L Wang et al. BRITISH JOURNAL OF CANCER
- Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
- (2010) Xiaolan Zhou et al. CELL
- Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm
- (2010) Jean-Pierre Vilardaga et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Signaling pathways perturbing muscle mass
- (2010) David J Glass CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways
- (2010) Alexander Doyle et al. FASEB JOURNAL
- Atorvastatin affects TLR4 clustering via lipid raft modulation
- (2010) Praveen Chansrichavala et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The TWEAK–Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice
- (2010) Ashwani Mittal et al. JOURNAL OF CELL BIOLOGY
- Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-κB-dependent activation of the urokinase plasminogen activator system
- (2009) S D Killeen et al. BRITISH JOURNAL OF CANCER
- Gender Disparities in Metastatic Colorectal Cancer Survival
- (2009) A. Hendifar et al. CLINICAL CANCER RESEARCH
- Medroxyprogesterone acetate in the management of cancer cachexia
- (2009) Clelia Madeddu et al. EXPERT OPINION ON PHARMACOTHERAPY
- Chronic Peroxisome Proliferator-activated Receptor γ (PPARγ) Activation of Epididymally Derived White Adipocyte Cultures Reveals a Population of Thermogenically Competent, UCP1-containing Adipocytes Molecularly Distinct from Classic Brown Adipocytes
- (2009) Natasa Petrovic et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The biology of activin: recent advances in structure, regulation and function
- (2009) Yin Xia et al. JOURNAL OF ENDOCRINOLOGY
- Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia
- (2009) Giovanni Mantovani et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)
- (2009) Aminah Jatoi et al. LUNG CANCER
- Cachexia: A new definition
- (2008) William J. Evans et al. CLINICAL NUTRITION
- Muscle myostatin signalling is enhanced in experimental cancer cachexia
- (2008) P. Costelli et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Rapamycin suppresses TLR4-triggered IL-6 and PGE2 production of colon cancer cells by inhibiting TLR4 expression and NF-κB activation
- (2008) Qiaoling Sun et al. MOLECULAR IMMUNOLOGY
- Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
- (2008) Bente K. Pedersen et al. PHYSIOLOGICAL REVIEWS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started